TCM
OM icon

TimesSquare Capital Management’s Outset Medical OM Stock Holding History

TimesSquare Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,225
Closed -$6.96M – 193
2022
Q2 		$6.96M Sell
31,225
-19,834
-39% -$8.53M 0.1% 166
2022
Q1 		$34.8M Sell
51,059
-14,192
-22% -$8.54M 0.39% 110
2021
Q4 		$45.1M Sell
65,251
-2,386
-4% -$1.76M 0.4% 109
2021
Q3 		$50.2M Sell
67,637
-372
-0.5% -$253K 0.44% 96
2021
Q2 		$51M Buy
68,009
+5,172
+8% +$3.95M 0.42% 100
2021
Q1 		$51.3M Buy
62,837
+9,909
+19% +$7.65M 0.44% 101
2020
Q4 		$45.1M Buy
52,928
+43,041
+435% +$33.2M 0.37% 118
2020
Q3 		$7.42M Buy
+9,887
New +$8.12M 0.07% 204

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TimesSquare Capital Management's OM Position: Q3 2022 in Review

TimesSquare Capital Management sold out of Outset Medical (OM) in Q3 2022, closing a stake of 31,225 shares — an estimated $6.96M sold.

TimesSquare Capital Management first reported a position in OM in Q3 2020 and held it in 8 quarters. The position peaked at $51.3M in Q1 2021. 138 funds tracked by Wall St. Rank hold OM as of Q3 2022.

  • TimesSquare Capital Management reported no remaining Outset Medical position as of Q3 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 31,225 Outset Medical shares in Q3 2022, an estimated $6.96M.
  • TimesSquare Capital Management first reported a position in Outset Medical in Q3 2020 and held it in 8 quarters.
  • TimesSquare Capital Management's Outset Medical position peaked at $51.3M in Q1 2021.
  • 138 funds tracked by Wall St. Rank held Outset Medical as of Q3 2022.

Based on TimesSquare Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.